Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System | Zendy

Márcio Debiasi | Zendy; Tomás Reinert | Zendy; Rafael Aliosha Kaliks | Zendy; Gilberto Amorim | Zendy; Maira Caleffi | Zendy; Carlos Eduardo Peres Sampaio | Zendy; Gustavo dos Santos Fernandes | Zendy; Carlos H. Barrios | Zendy

Open Access

Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System

Author(s) -

Márcio Debiasi,

Tomás Reinert,

Rafael Aliosha Kaliks,

Gilberto Amorim,

Maira Caleffi,

Carlos Eduardo Peres Sampaio,

Gustavo dos Santos Fernandes,

Carlos H. Barrios

Publication year - 2016

Publication title -

journal of global oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.002

H-Index - 17

ISSN - 2378-9506

DOI - 10.1200/jgo.2016.005678

Subject(s) - medicine , breast cancer , cancer , public health , estimation , oncology , gynecology , environmental health , family medicine , pathology , management , economics

Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic tumors treated in the public health system in Brazil do not have access to trastuzumab. This study aimed to estimate the impact of the lack of access to anti-HER2 therapies on the mortality of these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research